• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非胰岛素依赖型糖尿病患者的血浆8-表前列腺素F2α水平升高。

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus.

作者信息

Gopaul N K, Anggård E E, Mallet A I, Betteridge D J, Wolff S P, Nourooz-Zadeh J

机构信息

William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, UK.

出版信息

FEBS Lett. 1995 Jul 17;368(2):225-9. doi: 10.1016/0014-5793(95)00649-t.

DOI:10.1016/0014-5793(95)00649-t
PMID:7628610
Abstract

This study reports plasma levels of a specific nonenzymatic peroxidation product of arachidonic acid, esterified 8-epi-PGF2 alpha, from healthy- and NIDDM individuals as an index of oxidative stress in vivo. Plasma 8-epi-PGF2 alpha was isolated by solid-phase extraction on a C18 followed by an NH2 cartridge and analyzed by GC-MS/NICI as PFB-ester/TMS-ether derivative. We found that the average concentration of esterified 8-epi-PGF2 alpha among NIDDM subjects (0.93 +/- 0.07 nM, n = 39) was higher (P < 0.0001, Mann-Whitney test) than in healthy individuals (0.28 +/- 0.04 nM, n = 15). These data indicate that NIDDM is associated with increased plasma lipid peroxidation.

摘要

本研究报告了来自健康个体和非胰岛素依赖型糖尿病(NIDDM)个体的花生四烯酸特定非酶促过氧化产物——酯化8-表-前列腺素F2α的血浆水平,作为体内氧化应激的指标。血浆8-表-前列腺素F2α通过在C18柱上进行固相萃取,随后在NH2柱上进行萃取来分离,并通过气相色谱-质谱/负离子化学电离(GC-MS/NICI)分析其PFB-酯/TMS-醚衍生物。我们发现,NIDDM受试者中酯化8-表-前列腺素F2α的平均浓度(0.93±0.07 nM,n = 39)高于健康个体(0.28±0.04 nM,n = 15)(P < 0.0001,曼-惠特尼检验)。这些数据表明,NIDDM与血浆脂质过氧化增加有关。

相似文献

1
Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus.非胰岛素依赖型糖尿病患者的血浆8-表前列腺素F2α水平升高。
FEBS Lett. 1995 Jul 17;368(2):225-9. doi: 10.1016/0014-5793(95)00649-t.
2
Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.通过气相色谱/三级四极杆质谱法改进8-表-前列腺素F2α和F2-异前列腺素的定量:人类中8-表-前列腺素F2α的部分环氧化酶依赖性形成。
J Mass Spectrom. 1997 Dec;32(12):1362-70. doi: 10.1002/(SICI)1096-9888(199712)32:12<1362::AID-JMS606>3.0.CO;2-N.
3
Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.大鼠在环氧化酶抑制过程中尿8-表-前列腺素F2α减少,但人类并非如此。
Br J Pharmacol. 1997 Aug;121(8):1770-4. doi: 10.1038/sj.bjp.0701321.
4
Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure.气相色谱-质谱联用分析体内F2-异前列腺素作为非酶促脂质过氧化指标:固相萃取方法的建立
J Chromatogr B Biomed Appl. 1995 May 19;667(2):199-208. doi: 10.1016/0378-4347(95)00035-h.
5
Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha.环氧化酶依赖性异前列腺素8-表前列腺素F2α的形成。
J Biol Chem. 1995 Apr 28;270(17):9800-8. doi: 10.1074/jbc.270.17.9800.
6
Increased levels of plasma 8-EPI-PGF2α in patients with end stage renal failure.终末期肾衰竭患者血浆 8-异前列腺素 F2α 水平升高。
Redox Rep. 1997 Aug;3(4):207-11. doi: 10.1080/13510002.1997.11747111.
7
Plasma 8-epi PGF2 alpha levels in health and disease.
Adv Exp Med Biol. 1997;433:189-92.
8
Release of the lipid peroxidation marker 8-epi-prostaglandin F2 alpha from isolated gill pavement cells.从分离的鳃扁平细胞中释放脂质过氧化标志物8-表前列腺素F2α。
Environ Toxicol Chem. 2008 Jul;27(7):1569-75. doi: 10.1897/07-510.1.
9
8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo.8-表前列腺素F2α:作为体内氧化应激指标的异二十碳烷酸的特异性分析
Br J Clin Pharmacol. 1996 Jul;42(1):15-9. doi: 10.1046/j.1365-2125.1996.03804.x.
10
Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.有证据表明F2-异前列腺素,即8-表前列腺素F2α,是在体内形成的。
Biochim Biophys Acta. 1994 Jan 3;1210(2):244-8. doi: 10.1016/0005-2760(94)90128-7.

引用本文的文献

1
Major heme proteins hemoglobin and myoglobin with respect to their roles in oxidative stress - a brief review.主要血红素蛋白血红蛋白和肌红蛋白在氧化应激中的作用——简要综述
Front Chem. 2025 Feb 25;13:1543455. doi: 10.3389/fchem.2025.1543455. eCollection 2025.
2
Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae.释放硫化氢的化合物在离体牛视网膜中的神经保护作用
Pharmaceuticals (Basel). 2024 Oct 1;17(10):1311. doi: 10.3390/ph17101311.
3
Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease.
与饮食诱导的代谢功能障碍相关脂肪性肝病的青春期男孩肝脏脂肪减少相关的脂质组变化
Metabolites. 2024 Mar 28;14(4):191. doi: 10.3390/metabo14040191.
4
Insights into the Multifaceted Roles of Thioredoxin-1 System: Exploring Knockout Murine Models.硫氧还蛋白-1系统多方面作用的深入见解:探索基因敲除小鼠模型
Biology (Basel). 2024 Mar 12;13(3):180. doi: 10.3390/biology13030180.
5
Hydrogen peroxide detoxification through the peroxiredoxin/thioredoxin antioxidant system: A look at the pancreatic β-cell oxidant defense.通过过氧化物酶/硫氧还蛋白抗氧化系统进行过氧化氢解毒:探讨胰腺β细胞的氧化剂防御。
Vitam Horm. 2023;121:45-66. doi: 10.1016/bs.vh.2022.11.001. Epub 2022 Dec 29.
6
Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function.硫氧还蛋白还原酶缺失破坏了氧化还原稳态并损害了β细胞功能。
Function (Oxf). 2022 Jul 4;3(4):zqac034. doi: 10.1093/function/zqac034. eCollection 2022.
7
Redox signaling at the crossroads of human health and disease.人类健康与疾病交叉点上的氧化还原信号传导。
MedComm (2020). 2022 Mar 31;3(2):e127. doi: 10.1002/mco2.127. eCollection 2022 Jun.
8
Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes.氧化应激触发的信号通路与 2 型糖尿病的机制研究进展
Molecules. 2022 Jan 30;27(3):950. doi: 10.3390/molecules27030950.
9
Cellular targets in diabetic retinopathy therapy.糖尿病视网膜病变治疗中的细胞靶点。
World J Diabetes. 2021 Sep 15;12(9):1442-1462. doi: 10.4239/wjd.v12.i9.1442.
10
The Role of Thioredoxin/Peroxiredoxin in the β-Cell Defense Against Oxidative Damage.硫氧还蛋白/过氧化物酶在β细胞抵抗氧化损伤中的作用。
Front Endocrinol (Lausanne). 2021 Sep 7;12:718235. doi: 10.3389/fendo.2021.718235. eCollection 2021.